I nternat iona l Societ y

Size: px
Start display at page:

Download "I nternat iona l Societ y"

Transcription

1 ProgramME I nternat iona l Societ y of Haematolog y Congress of the European & African Division Budapest, Hungary 9 August September, 007 Budapest Congress & World Trade Center 3 Jagello street, Budapest, 3 Introduction w w w.ish-ead0 07.hu

2 Time Wednesday 9 August 007 Thursday 30 August 007 Time EDUCATIONAL SESSION Acute Leukaemia Coffee Break (Exhibition Area) PRESIDENTIAL SYMPOSIUM Stem Cell Transplantation SATELLITE SYMPOSIUM Haemostasis EDUCATIONAL SESSION Stem Cell Transplantation Lunch Break, Poster Viewing (Gallery Level) SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM Risk adapted management of CLL EDUCATIONAL SESSION Lymphoma Enerca Symposium Immigration and Haematology (Bartók Room) Coffee Break (Exhibition Area) ORAL PRESENTATIONS 530 SATELLITE SYMPOSIUM ATG-Fresenius its role in conditioning treatment prior to stem cell transplantation Acute Leukaemia Haemostasis (Bartók Room) SATELLITE SYMPOSIUM SATELLITE SYMPOSIUM MabThera increasing survival 800 Novartis Symposium 800 in non-hodgkin Lymphoma OPENING CEREMONY WELCOME PARTY (Congress Venue) PROGRAMME-AT-A GLANCE

3 Time Friday 3 August 007 Saturday September 007 Time EDUCATIONAL SESSION Stem Cell Transplantation EDUCATIONAL SESSION Infections in Haematology Coffee Break (Exhibition Area) ISH-EAD Science and Education Committee Meeting (Brahms Room) Coffee Break (Exhibition Area) EDUCATIONAL EDUCATIONAL SESSION SESSION 00 Myeloproliferative Disorders 00 Transfusion Medicine ISH-EAD Lunch Break, Poster Divisional Meeting Viewing (Brahms Room) Lunch Break, Poster Viewing (Gallery Level) ISH-EAD (Gallery Level) General Assembly (Brahms Room) SATELLITE SYMPOSIUM 330 EDUCATIONAL Teva Symposium EDUCATIONAL SESSION SESSION Stable Blood Product 400 Haemostasis 400 Anaemia Service in Hungary (in Hungarian language) 430 (Bartók Room) 430 HEMOPHILIA 500 Coffee Break (Exhibition Area) Coffee Break (Exhibition Area) Expert panel 500 discussion with 530 ORAL PRESENTATIONS patient participation 530 (Bartók II Room) ORAL PRESENTATIONS MEET THE EXPERT 600 Blood Transfusion Chronic Myeloproliferative Experimental 600 (Bartók Room) Anaemia Hematology Diseases 630 (Brahms Room) (Bartók Room) ORAL PRESENTATIONS ORAL PRESENTATIONS Stem Cell 800 Lymphoma I. Miscellaneous Lymphoma II. Transplantation (Bartók Room) 830 (Bartók Room) ORGAN CONCERT (St. Stephan s Basilica) GALA DINNER (Hungarian National Gallery) 000 PROGRAMME-AT-A GLANCE

4 Wednesday 9 August 007 Number after the title in brackets is to identify the abstract in the Blood Reviews Satellite Symposium Haemostasis Pátria Room Sponsored by: Comesa Kft.; Instrumentation Laboratory & Novo Nordisk Hungária Kft Break 00. Management of inhibitors in hereditary hemophilia Speaker: to be announced 00. Antiphospholipid antibodies: Diagnosis and clinical course Speaker: Prof. Dr. Paolo Simioni, University of Padua Medical School Satellite Symposium Risk adapted management of CLL Pátria Room Chairpersons: Michael Hallek (Germany), Hajna Losonczy (Hungary) Break 330 Welcome and introduction Hajna Losonczy (Hungary) New and traditional prognostic factors and their therapeutic significance Robin Foà (Italy) Risk adapted first line therapies Michael Hallek (Germany) Relapse strategies Michael Keating (USA) Stem cell transplantation Emili Montserrat (Spain) Summary and closing remarks Michael Hallek (Germany) Supported by Bayer Schering Pharma Wednesday 3

5 Satellite Symposium ATG-Fresenius its role in conditioning treatment prior to stem cell transplantation Pátria Room Chairperson: Tamás Masszi (Hungary) Break Long Term Experience of ATG-Fresenius S in Bone Marrow Transplantation Karin Kolbe (Mainz, Germany) The FLAMSA-RIC Regimen: Exploiting the GvL Effect in Allogeneic Stem Cell Transplantation for High Risk Myeloid Malignancies Michael Schleuning (Wiesbaden, Germany) ATG-Fresenius as Prevention of Severe GvHD in Children after Stem Cell Transplantation using Unrelated Donors Petr Sedlacek (Prague, Czech Republic) Satellite Symposium MabThera increasing survival in non-hodgkin Lymphoma. Pátria Room Chairpersons: Sándor Fekete (Hungary), Zita Borbényi (Hungary) 00. Chairs welcome and introduction Sándor Fekete Szent László Hospital, Hematology Department, Budapest, Hungary Zita Borbényi nd Department of Medicine and Cardiology Center, Medical Faculty, University of Sciences Szeged, Hungary 00. Optimising induction therapy in follicular lymphoma Michael Herold Helios Klinikum,Leiter Hämatologie/Onkologie. Medizinische Klinik Erfurt, Germany 003. Rituximab maintenance therapy for relapsed follicular lymphoma Pieter Sonneveld Erasmus Medical Center, Department of Hematology Rotterdam, The Netherlands 004. Improvement of therapeutic results in diffuse large B-cell lymphoma in Hungary following R-CHOP chemo-immunotherapy Tamás Schneider National Institute of Oncology, Budapest, Hungary Sponsored by F. Hoffman-La Roche Ltd. Opening Ceremony 930 Pátria Room Welcome party 000 Shuttle buses will depart to the Hotels after the Welcome Party Congress Venue 4 Wednesday

6 Thursday 30 August 007 Number after the title in brackets is to identify the abstract in the Blood Reviews Educational Session Acute Leukaemia Pátria Room Chairpersons: Dieter Lutz (Austria), Sándor Fekete (Hungary) 00. AML with normal Caryotype Wolfgang Hiddemann (Germany) 00. Current treatment of AML, novel approaches Alan K. Burnett (UK) 003. Treatment of acute lymphoblastic leukemia in adults [I7] Dieter Hoelzer (Germany) 004. Role of hypomethylating agents in the treatment of AML and MDS John DiPersio (USA) Coffee Break Exhibition Area Presidential Symposium Stem Cell Transplantation Pátria Room Chairpersons: Emin Kansu (Turkey), Zsuzsa Hollán (Hungary), Sándor Fekete (Hungary), Zita Borbényi (Hungary), Tamás Masszi (Hungary) Cord blood transplantation Eliane Gluckman (France) Educational Session Stem Cell Transplantation Pátria Room Chairpersons: Emin Kansu (Turkey), Tamás Masszi (Hungary) Poster Viewing 00. Stem cell transplantation with reduced intensity conditioning Dietger Niederwieser (Germany) 00. Haploidentical transplantation for acute leukemia [I0] Isabel Cunningham (USA) 003. GVHD and extracorporeal photopheresis [I0] Hildegard T. Greinix (Austria) List of the posters can be found on page Gallery Level Lunch Break Gallery Level Thursday 7

7 Educational Session Lymphoma Pátria Room Chairpersons: Roman Hajek (Czech Republic), Hajna Losonczy (Hungary) 00. Treatment of high grade NHL Cesare Guglielmi (Italy) 00. Novelties in the treatment of multiple myeloma Heinz Ludwig (Austria) 003. Current treatment strategies of Hodgkin disease Andreas Josting (Germany) 004. CLL treatment in 007 Emili Montserrat (Spain) Enerca Satellite Symposium Enerca Satellite Symposium Bartók Room Immigration and Haematology: Towards the Prevention of Haemoglobinopathies in Europe Haemoglobinopathies in Europe The Current Perspective Barbara Bain (UK) Genetic Counselling on Haemoglobinopathies. New Challenges. Patricia Aguilar Martinez (France) Establishment of National Neonatal Screening Programmes for Haemoglobinopathies in Europe Beatrice Gulbis (Belgium) WHO Resolutions for the Prevention and Management of Haemoglobinopathies and Thalassaemia in Europe Victor Boulyjenkov (WHO International) ENERCA: A European Reference Network for Rare Anaemias Joan Lluis Vives Corrons (Spain) Discussion Coffee Break Exhibition Area Oral Presentations Acute Leukaemia Pátria Room Chairpersons: Ray Lowenthal (Australia), Zita Borbényi (Hungary) 00. Twenty-five years of clinical trials for adult Acute Myeloid Leukaemia (AML) in Australia [O0] R. M. Lowenthal *, J. F. Seymour, on behalf of the Australasian Leukaemia/Lymphoma Group (ALLG) Department of Haematology/Oncology, Royal Hobart Hospital, Hobart, Tasmania, Australia 00. The effects of transporter gene polymorphisms on the immunosuppressive effects of chemotherapy in childhood acute lymphoblastic leukemia (ALL) [O0] G. T. Kovacs *, D. J. Erdelyi, A. Semsei, E. Kamory 3, M. Csoka, A. Tordai 4, C. Szalai nd Department of Pediatrics, Semmelweis University, Budapest, Hungary, Dept. of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary, 3 Laborigo Molecular Diagnostics Ltd, Budapest, Hungary, 4 Dept. of Molecular Diagnostic, National Medical Center, Budapest, Hungary 8 Thursday

8 003. Our experience with the Hong Kong-Singapore Acute Lymphoblastic Leukaemia 97 protocol [O04] S. Y. Soh *, M. Y. Chan, A. M. Tan Haematology/Oncology Service, Dep. of Paediatric Subspecialties, KK Women s and Children s Hospital, Singapore 004. Leukemic tumors in the ovary [O05] I. Cunningham * Columbia University, Hematology Oncology, New York, NY, USA 005. Bortezomib+chemotherapy based salvage combinations in refractory AML, preliminary results [O06] M. Udvardy *, A. Kiss, B. Telek, R. Szasz, P. Batar, G. Remenyi, E. Mehes, L. Rejto Dept. of Hematology, University Health Science, Debrecen, Hungary 006. Dexamethasone versus methyl-prednisolone for adult acute lymphoblastic leukaemia (ALL) and non- Hodgkin lymphoma (NHL) in patients 60 yrs old: final results of the EORTC ALL-4 Phase III Trial [O07] B. Labar *, S. Suciu, P. Muus, R. Willemze, J.-P. Marie, G. Fillet, Z. Berneman, B. Jaksic, W. Feremans, D. Bron, H. Sinnige, M. Mistrik, G. Vreugdenhil, R. De Bock, D. Nemet, C. Gilotay, T. de Witte, S. Amadori Leukemia Group, EORTC, Belgium, Department of Hematology, University Hospital Rebro, Zagreb, Croatia 007. Genetics of acute lymphoblastic leukaemia (ALL) in childhood [O03] É. Oláh *, E. Balogh, Z. Jakab, B. Bessenyei, A. Ujfalusi Clinical Genetic Center, Dept. of Pediatrics, Medical and Health Science Center, University of Debrecen, Hungary Oral Presentations Haemostasis Bartók Room Chairpersons: Nabil Abdelrazik (Kingdom of Saudi Arabia), Zoltán Boda (Hungary) Break 00. Rare bleeding disorders in Slovakia genotype and phenotype characteristics [O] A. Batorova *, D. Horvathova, D. Jankovicova, M. Mistrik National Hemophilia Center, Dept. of Hematology, University Hospital, Bratislava, Slovakia 00. Pulmonary embolism in a Hungarian Teaching Hospital [P05] M. Egyed *, P. Zádori, A. Horváth, G. Horváth Kaposi Mór Teaching Hospital, Kaposvár, Hungary 003. Study of the most common inherited thrombophilias in HELLP syndrome patients [O09] P. Hupuczi *, B. Nagy, B. Rigó, G. Szabó, E. Berkes, I. Sziller, Z. Papp st Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary 004. Evaluation of bone mineral density in children with hemophilia: Mansoura University Children Hospital (MUCH) experience, Mansoura, Egypt [O0] N. Abdelrazik *, M. Reda, M. El-Ziny, H. Rabea Mansoura University Children s Hospital, Mansoura Faculty of Medicine, Mansoura, Egypt 005. Genetic analysis of the coagulation factor VIII and IX genes in Hungarian families with haemophilia [O] A. Bors *, H. Andrikovics, A. Szilvási, Zs. Illés, A. Marosi, L. Nemes, A. Tordai Institute of Haematology and Immunology, National Medical Center, Budapest, Hungary, Heim Pál Children s Hospital, Budapest, Hungary 006. Ten years follow up of hereditary hemorrhagic patients in the dental practice [O3] S. P. Makris *, M. P. Makris, A. Papadopoulos, P. E. Makris Haemostasis and Thrombosis Unit, Aristotle University of Thessaloniki, Greece Satellite Symposium Novartis Symposium Pátria Room Thursday 9

9 Posters Experimental 00. Variations in culture conditions profoundly alter the lipid composition of mammalian cells: implications for the stress response modulation [P04] S. Benkő 3 *, G. Balogh, I. Horváth, G. Liebisch, A. Maslyanko, G. Schmitz, JL. Harwood 4, L. Vígh Inst. Biochem. Biological Research Center, Szeged, Hungary, Inst. for Clin. Chem. and Lab. Medicine, Univ. of Regensburg, Germany, 3 Outpatient Medical Centre, Municipality of Szeged, Hungary, 4 School of Biosciences, Cardiff University, Wales, UK 00. Serum level of intercellular adhesion molecule-(icam-) in patients with malignant lymphoma [P05] N. Abdelrazik *, M. Fouda, M.H. El-deen Zaghloul 3, D. Abbas 4 Department of Pediatrics, Pediatric Hematology, Oncology, and BMT unit, Mansoura University Children Hospital (MUCH), Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt, Department of hematology, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt, 3 Department of Clinical Pathology, Mansoura Faculty of Medicine, Mansoura University, Mansoura, Egypt, 4 Department of clinical pathology, Mansoura Health Insurance Hospital, Mansoura, Egypt 003. Evaluation of P-selectin in patients with acute coronary syndrome [P06] N. Mowafy *, M.A. Ali, S. Allam, L. Emam Al Azhar Faculty of Medicine, Departments of Clinical Pathology and Cardiology, Cairo, Egypt 004. The state of phosphoinositide cycle components at chronic lympholeukosis and after polychemotherapy [P07] P.A. Ghazaryan *, S.S. Daghbashyan, K.I. Israelyan Haematological center, Department of Biochemistry, Yerevan, Armenia 005. Modification of proteome and secretome during activation of human blood platelets [P08] A. Sobotková *,P.Májek, R. Kotlín, J. Suttnar, J.E. Dyr Institute of Hemotology and Blood Transfusion, Department of Biochemistry, Prague, Czech Republic 006. First report about a toxic sialadenosis of the parotis during induction and re-intensification of acute lymphoblastic leukemia [P09] G. Ottóffy *, Á. Vojcek, E. Cholnoky, E. Kálmán, G. Szalai 3, P. Kajtár Oncohaematological Unit of the Pediatric Department, Hungary, Pathology Department and 3 Radiology Department of the University of Pécs, Hungary 007. The regulation of metabolism of cellular lipids after using a cyan-containing derivative of lactone associated with sarcoma-45 [P030] P.A. Ghazaryan *, G.M. Galoyan, A.S. Karagulyan Yerevan State University, Haematology Center MH RA, 37504, 7 H.Nersisyan str., Armenia 008. The immediate effect of submaximal aerobic exercise on haemostatic and endothelium associated cardiovascular risk factors in patients never treated for their hypertension [P03] V. Galea *, T. Theodoridis, M. El Ali, S. Aidonopoulos, H. Triantafyllifidi, J. Lekakis, M. Koutrroubi, V. Cokkinou, D. Kremastinos Haematology Laboratory, Evangelismos Hospital, Athens, Greece, nd Cardiology Department, Medical School, University of Athens, Attikon Hospital, Greece 009. Impact of phospholipid-phospholipid ratios on the activity of 5-nucleotidase in lymphocytes at lymphogranulomatosis [P03] A.A. Pepanyan *, A.H. Asoyan Haematology Center Ministry of Health Republic of Armenia, Yerevan 00. Vacuolated alveolar rhabdomyosarcoma cells mimicking FAB L3 lymphoblasts in bone marrow [P033] G. Ottóffy *, B. Kajtár, L. Kereskai, T. Tornóczky, K. Csernus, P. Kajtár Oncohaematological Unit of the Pediatric Department, University of Pécs, Hungary, Pathology Department of the University of Pécs, Hungary 0. Fas/FasL expression on neutrophils and lymphocytes of chronic renal failure and hemodialysis patients [P034] N. M. Zahran *, B. A. Madkour, N. A. Hussein, O. M. Sabry, E. Waked Departments of Hematology, Theodor Bilharz Research Institute, Giza, Egypt, Departments of Nephrology, Theodor Bilharz Research Institute, Giza, Egypt 0. Implementation of the ISLH criteria for action following automated CBC and WBC differential analysis [P035] M.L. Udvardy *, J. Kappelmayer, A. Molnár, V. Szűcs, Zs. Hevessy University of Debrecen, Medical and Health Science Center, Department of Clinical Biochemistry and Molecular Pathology, Debrecen, Hungary, International System House Ltd., Budapest, Hungary 03. About mechanisms of development of endogenous intoxication and its correction under radiation stress [P038] L.S. Sahakyan *, P.A. Ghazaryan, A.A. Galoyan, A.V. Tovmasian Center of Haematology of RA, Institute of Biochemistry NAS RA, Armenia 04. Cooperativity between bone marrow cells and cultureexpanded mesenchymal stem cells during reversal of type- diabetes [P039] V.S. Urbán *, J. Kiss, J. Kovács, V. Vas, É. Monostori 3, F. Uher Stem Cell Biology, NMC, Budapest, Hungary, Dep. of Anatomy, Cell and Developmental Biology, ELTE, Budapest, Hungary, 3 Lymphocyte Signal Transduction Laboratory, BRC, Szeged, Hungary Thursday

10 05. Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells [P039A] L. Markasz, *, G. Stuber, E. Flaberg, Å. Gustafsson Jernberg 3, S. Eksborg 4, E. Olah, H. Skribek, L. Szekely Department of Microbiology, Tumor and Cell Biology (MTC) and Center for Integrative Recognition in the Immune System (IRIS), Karolinska Institute, Box 80 S-777 Stockholm, Sweden, Department of Pediatrics University of Debrecen, Medical and Health Science Center, Debrecen, Hungary, 3 Department of Pediatrics, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden, 4 KarolinskaPharmacy, and Department of Woman and Child Health, Childhood Cancer Research Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden Haemostasis 06. Coagulation disorders and inhibitors of coagulation in children: cases from Mansoura, Egypt [P040] N. Abdelrazik *, H. Rashad, T. Selim, L. Tharwat Department of Pediatrics, pediatric hematology, oncology,and BMT unit, Mansoura University Children Hospital (MUCH), Egypt, Department of clinical pathology, Mansoura Faculty of Medicine, Mansoura, Egypt 07. Thrombin generation among Sudanese essential hypertension patients [P04] F.M. Hassan *, M. M. Hamid, A. Nagi 3 College of Medical Laboratory Science, Sudan University of Science and Technology, Sudan, Faculty of Medicine, University of Khartoum, Sudan, 3 College of Medical Laboratory Science, Sudan University of Science and Technology, Sudan 08. Changes in the life of the West-Transdanubian Hemophilia Region of Hungary [P04] K. Vörös *, R. Jáger, K. Takács Regional Blood Center Győr, Hungary, Blood Bank Szombathely, Hungary 09. PAI- 4G/5G polymorphism in a cohort of patients with thrombosis and antiphospholipid antibodies (APA) [P043] M. Bellia *, G. Apergis, A. Gafou, S. Sklavou, E. Pavlou, V. Papadopoulou, G. Theodosiades, E. Andrioti Transfusion, Haemophilia Center, Hippokrateion Hospital, Athens, Greece 00. A study of factor V mutation among a group of unexplained thrombosis in Egypt [P044] N. Mowafy *, H.H. El Khaleegy, E. Motawei, A.T. Labeeb, M. H. Rizk Al Azhar Faculty of Medicine, Clinical Pathology and Surgery Departments, Cairo, Egypt 0. The treatment of the life-treatening bleeding in haemophiliacs and in patients with acute leukaemia. Our experience [P045] D. Pejin *, S. Popovic, E. Gebauer, K. Popovic, I. Savic, A. Savic, N. Rajic, B. Zeravica Academy of Medical Science, Novi Sad, Serbia, Clin. of Haematology, Novi Sad, Serbia 0. The use of rotation thrombelastography in familial thrombophilia [P046] O. Tóth *, N. Lima, M. Dávid, Á. Nagy, H. Losonczy University of Pécs, Ist Dept. of Internal Medicine, Pécs, Hungary 03. Acquired dysfibrinogenemia associated with multiple myeloma [P047] R. Kotlín *, A. Sobotková, J. Suttnar, P. Salaj, T. Riedel, J.E. Dyr Department of Biochemistry, Institute of Hematology and Blood Transfusion, Praha, Czech Republic 04. The significance of ultrasonic investigation in the urgent diagnostics of internal hemorrhage in patients with hemophilia [P048] R.V. Avagyan * Hematological Center MPH, Yerevan, Armenia 05. Could heparin-induced thrombocytopenia and thrombosis be a rare manifestation of antiphospholipid antibody syndrome? [P049] Z. Olah *, Á. Schlammadinger, J. Mikita, P. Ilonczai, K. Razso, Z. Bereczky, Z. Boda University of Debrecen, Medical and Health Science Center, nd Department of Medicine, Debrecen, Hungary, Clinical Research Center, Debrecen, Hungary 06. Successful immune tolerance induction treatment of therapy-resistent acquired haemophilia with high inhibitor titer: a case report [P050] P. Ilonczai *, A. Schlammadinger, Zs. Oláh, K. Rázsó, Zs. Bereczky, Z. Boda University of Debrecen, Medical and Health Science Center, nd Department of Medicine, Division of Haemostasis, Debrecen, Hungary, Clinical Research Center, Debrecen, Hungary 07. Association between CYPC9 polymorphism and warfarin dose [O08] M. Samardžija *, E. Topić, M. Štefanović, L. Zibar 3, G. Samardžija 3, S. Balen 4, A. Včev 3, D. Domanović 5, J. Barbić 3, D. Petrak, V. Šišljagić 6 Department of Transfusion medicine, Osijek University hospital, Osijek, Croatia, Clinic institute of chemistry, School of medicine Zagreb University, Sestre milosrdnice University hospital, Zagreb, Croatia, 3 Clinic of Internal medicine, Osijek University hospital, Osijek, Croatia, 4 Department of Transfusion medicine, Rijeka University Hospital Centre, Rijeka Croatia, 5 Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia, 6 Clinic of Surgery, Osijek University hospital, Osijek, Croatia 08. Low dose factor concentrate prophylaxis in patients with severe haemorrhagic disorders [P05] Á. Schlammadinger *, P. Ilonczai, Zs. Oláh, K. Rázsó, Z. Boda nd Department of Medicine, Division of Haemostaseology, Institute of Internal Medicine, University of Debrecen, Debrecen, Hungary 09. Coinheritance of FV-Leiden mutation and FV-HR [P053] M. P. Makris *, S. I. Papamichos, A. Kanidis, P. E. Makris Aristotle University of Thessaloniki, Greece 030. Influence of chronic hemodialysis on the level of plasma fibrinogen in patients with chronic renal failure [P054] C. D. Čeleketić *, Z. Cvetković, V. Vukov, D. Kostić Clinical Hospital Zemun, Department of Hematology and Immunology, Zemun, Belgrade, Serbia 03. Catastrophic antiphospholipidic syndrome [P055] A. Komnos, Th. Paraforou, G. Paraforos, V. Christodoulou, A. Chovas, Th. Chatzopoulos, G. Toulis, A. Gerotziafa, S. Papamichos, M. P. Makris *, G. Koliakos, P. E. Makris Intensive Care General Hospital Larisa, Laboratory of Haematology and Haemostasis Biohellenika Co. Thessaloniki, Greece Thursday

11 03. Platelet-endothelial interaction in patients with chronic liver diseases [P056] N. M. Zahran *, O. M. Mahmoud, M. Y. Zahran, S. M. Shendy Department of Haematology, Theodor Bilharz Research Institute, Giza, Egypt 033. Chronic relapsing thrombotic thrombocytopenic purpura in a 3 years old diabetic male with ADAMTS 3 protease deficiency treated succesfully with plasma infusions and steroids [P057] A.T. Lopez-Enriquez * Puerto Rico 034. Type I plasminogen deficiency ligneous conjunctivitis [P058] E. Maka *, G. Veres, J.Bókay, P. Domsa, O. Lukáts Department of Ophthalmology, Semmelweis University, Budapest, Hungary, st Department of Pediatrics, Semmelweis University, Budapest, Hungary 035. PAI- 4G/5G polymorphism and antiphospholipid antibodies (APA) in pregnancy complications [P059] M. Bellia *, G. Apergis, A. Gafou, E. Nomikou, E. Pevlou, C. Zafiri, E. Andrioti Transfusion-Haemophilia Center, Hippokrateion Hospital- Athens-Greece 036. Molecular genetic results of Transdanubian haemophilic patients [P060] Á. Nagy *, A. Szomor, M. Kecskés, W. Schröder, F.H. Herrmann, H. Losonczy Pécs University, Faculty of Medicine, st department of Internal Medicine, Hungary, Institut für Humangenetik, Ernst Moritz- Arndt Universität, Greifswald, Germany 037. Type 3 von Willebrand disease in Hungary: A partial large deletion is the most common genetic defect [P06] A. Mohl *, Z. Boda 4, R. Jager 4, H. Losonczy 4, A. Marosi 4, T. Masszi 3, E. Nagy, L. Nemes 3, T. Obser, F. Oyen, G. Radványi 4, K. Sallai, Á. Schlammadinger 4, Zs. Szélessy 3, K. Vezendy 4, R. Schneppenheim, I. Bodó,3 Semmelweis University Budapest, Hungary, Eppendorf University Hamburg, Germany, 3 National Medical Center, Budapest, Hungary, 4 Investigators of the von Willebrand Disease in Hungary project, Hungary 038. Relationship between insulin resistance and some coagulation and fibrinolytic parameters in subjects with metabolic syndrome [P59] A. Ragab *, N. Abou Samra, A. Higazy, O. Saleh Departments of Clinical Pathology and Internal Medicine, Faculty of Medicine, Mansoura University, Egypt 039. Temporal variations of aspirin resistance in patients with acute coronary syndrome [P6] M. Tsekoura *, T. Papaioannou, M. Vavuranakis, Z. Palantza, G. Rossos, C. Stefanadis, E. Bossinakou Hematology Dept., Dept. of Cardiology, University of Athens Hippokration Hospital, Greece 040. Search of mutations in the gene of VKORC in Greek patients [P6] A. Vasiliki, M. P. Michalis, K. Athanassios, K. Georgios, M. E. Pantelis Biohellenika Haemostasis Research unit, Aristotle University of Thessaloniki, Greece Stem Cell Transplantation 04. Demographic, health and psychosocial aspects of quality of life in acute myeloid leukaemia survivors treated by means of autologous progenitor stem cell transplantation [P00] L. Slovacek,,3 *, B. Slovackova 4, L. Jebavy,, J. M. Horacek, Department of Field Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic, Department of Clinical Haematology of the nd Department of Internal Medicine of Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic, 3 Department of Clinical Oncology and Radiotherapy of Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic, 4 Department of Psychiatry, Charles University Hospital and Medical Faculty, Hradec Králové, Czech Republic 04. Quality of life in patients with Hodgkins and non- Hodgkins malignant lymphoma and multiple myeloma treated by means of autologous haematopoietic stem cell transplantation: an effect of selected demographic, psychosocial and health aspects on quality of life [P00] L. Slovacek,,3 *, B. Slovackova 4, L. Jebavy, Department of Field Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic, Department of Clinical Haematology, Department of Medicine, Charles University Hospital and faculty of Medicine, Hradec Kralove, Czech Republic, 3 Department of Clinical Oncology and Radiotherapy, Charles University Hospital and faculty of Medicine, Hradec Kralove, Czech Republic, 4 Department of Psychiatry, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic 043. Quality of life in acute myeloid leukaemia and multiple myeloma survivors undergoing autologous progenitor stem cell transplantation: a retrospective analysis [P003] L. Slovacek,,3 *, B. Slovackova 4, L. Jebavy, Department of Field Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic, Department of Clinical Haematology, nd Internal Clinic of Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic, 3 Department of Clinical Oncology and Radiotherapy, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic, 4 Department of Psychiatry, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic 044. Male sexuality versus haematopoietic stem cell transplantation: a form of review [P004] L. Slovacek,,3 *, B. Slovackova 4, Z. Macingova 3, J.M. Horacek,, L. Jebavy,, M. Blazek Department of Field Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic, Department of Clinical Haematology, nd Internal Clinic of Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic, 3 Department of Clinical Oncology and Radiotherapy, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic, 4 Department of Psychiatry, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic Thursday 3

12 045. Multimarker approach to assessment of cardiac toxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia [P005] J.M. Horacek, *, M. Tichy,3, L. Jebavy,, R. Pudil 4, P. Zak, V. Blaha, L. Slovacek,, V. Palicka 3 Faculty of Military Health Sciences, Department of Internal Medicine, Hradec Kralove, Czech Republic, Charles University Hospital, Department of Medicine II Clinical Hematology, Czech Republic, 3 Institute of Clinical Biochemistry and Diagnostics, Czech Republic, 4 Department of Medicine I, Hradec Kralove, Czech Republic 046. Infusion of hematopoietic cell graft and its impact on blood pressure and heart rate [P006] J.M. Horacek, *, L. Jebavy,, M. Jakl, L. Slovacek,, P. Zak, M. Brndiar, L. Kacerovky Faculty of Military Health Sciences, Department of Internal Medicine, Hradec Kralove, Czech Republic, Charles University Hospital, Department of Medicine II, Clinical Hematology, Hradec Kralove, Czech Republic 047. Galectin- inhibits hematopoietic stem and progenitor cell mobilization [P007] J. Kiss *, A. Kunstár, R. Fajka-Boja, V. Dudics,3, J. Tóvári 4, Á. Légrádi, E. Monostori, F. Uher Stem Cell Biology, NMC, Budapest, Hungary, Lymphocyte Signal Transduction Laboratory, BRC, Szeged, Hungary, 3 Polyclinic of Hospitaller Brothers of St. John of God, Budapest, Hungary, 4 Dep. of Tumor Progression, NIO, Budapest, Hungary 048. Characterization of umbilical cord blood hematopoietic stem, progenitor cell subsets and mesenchymal stem cell lines: a Hungarian cord blood bank report [P008] V. Vas *, K. Vraukó, N. Regéczy, R. Schwáb 3, B. Sarkadi National Medical Center, Stem Cell Biology, Hungary, NMC, Institute of Hematology and Immunology, Membrane Research Group, Hungary, 3 NMC, Human Biotech KKK, Hungary 049. High-risk patients with aggressive non-hodgkin lymphoma should benefit from autologous stem cell transplantation in first remission (single-centre experience) [P009] S. Genadieva Stavrik *, L. Cevreska, Z. Stojanoski, A. Pivkova, A. Stojanovik, S. Krstevska Balkanov, O. Karanfilski, B. Georgievski University Clinical Center, Department of Hematology Skopje, Macedonia 050. Zevalin-beam conditioning therapy by autologous peripheral stem cell transplantation in follicular non- Hodgkin lymphoma patients [P00] Gy. Reményi *, A. Kiss, P. Batár, R. Szász, G. Radványi, M. Udvardy University of Debrecen, Debrecen, Hungary, Internal Medicine of Semmelweis Hosp., Miskolc, Hungary 05. Myeloablative stem cell transplantation for imatinib resistant advanced phase CML: chronic GVHD indicates better disease control [P0] A. Bátai *, P. Reményi, B. Kapás, A. Sipos, Z. Csukly, S. Lueff, M. Réti, V. Goda, T. Masszi National Medical Centre, BMT Unit, Budapest, Hungary 05. Complete resolution of Behcet s disease after HLA-mismatched allogeneic peripheral haematopoietic stem cell transplantation for myelodysplastic syndrome case report [P03] L. Gopcsa *, A. Barta, E. Torbagyi, L. Lengyel, K. Kallay, R. Rasonyi, A. Tremmel, J. Csomor, J. Kadar 3, S. Lueff 4, G. Krivan St Laszlo Hospital, Department of Bone Marrow Transplantation, Hungary, St Laszlo Hospital, Department of Pathology, Hungary, 3 St Laszlo Hospital, Department of Immunology, 4 National Medical Center, Budapest, Hungary 053. Comparing of results of allogenic haemtopoietic stem cell transplantation with different conditioning regiments in children with acute leukemias [P04] E. Semenova *, N. Stancheva, M. Ovsyannikova, O. Paina, N. Zubarovskaya, B.V. Afanasyev Saint Petersburg State Medical Pavlov University, BMT Clinic, Russia 054. Quality of life in haematooncological patients treated with hematopoietic stem cell transplantation: definition, conception and measurement [P05] L. Slovacek,,3 *, B. Slovackova 4, Z. Macingova 3, V. Pavlik 5 Department of Field Internal Medicine, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic, Department of Clinical Haematology of the nd Department of Internal Medicine of Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic, 3 Department of Clinical Oncology and Radiotherapy of Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic, 4 Department of Psychiatry, Charles University Hospital and Medical Faculty, Hradec Králové, Czech Republic, 5 Department of Hygiene, Faculty of Military Health Sciences, University of Defence, Czech Republic 055. Allogeneic haemopoietic stem cell transplantation in children with acute leukemias. A single centre experience in Hungary (99 007). [P06] G. Kriván *, K. Kállay, A. Tremmel, M. Réti, R. Rásonyi, P. Reményi, A. Barta, L. Gopcsa, É. Torbágyi, L. Lengyel, T. Masszi St. László Hospital, BMT Unit, Budapest, Hungary 056. Transfusion associated GVHD and lymphoma after autologous stem cell transplantation in a patient with multiple myeloma [P07] R. Szász *, L. Rejtő, A. Kiss, M. Udvardy Department of Hematology, nd Department of Internal Medicine, University of Debrecen HSC, Debrecen, Hungary 057. Autologous bone marrow-derived stem cell transplantation in severe peripheral arterial disorder: the first five patients in Hungary [P08] M. Szarvas *, K. Rázsó, Zs. Oláh, P. Ilonczai, K. Farkas, J. Tóth 3, L. Jámbor 3, P. Soltész 4, K. Litauszky 5, J. Hunyadi 6, T. Sipos 6, J. Kappelmayer 7, Z. Veréb 8, É. Rajnavölgyi 8, Z. Boda University of Debrecen, Medical and Health Science Center, nd Department of Internal Medicine, Department of Haemostaseology, Debrecen, Hungary, Szent Imre Hospital, Internal Medicine- Angiology, Budapest, Hungary, 3 Department of Radiology, Debrecen, Hungary, 4 3rd Department of Internal Medicine, Debrecen, Hungary, 5 st Department of Surgery, Debrecen, Hungary, 6 Celltherapy Medical Center, Debrecen, Hungary, 7 Department of Clinical Biochemistry and Molecular Pathology, Debrecen, Hungary, 8 Depatrment of Immunology, Debrecen, Hungary 4 Thursday

13 058. Regulatory T cell (Treg) reconstitution following high-dose chemotherapy and autologous stem cell transplant in multiple myeloma, palifermin (Kepivance) may accelerate early Treg response, preliminary results [P09] M. Udvardy *, A. Kiss, B. Telek, R. Szasz, P. Batar, G. Remenyi, E. Mehes, L. Rejto, S. Sipka Dept. of Hematology and Regional Immunological Laboratory, Hungary, University Health Science, Debrecen, Hungary 059. HLA in hematopoietic stem cell transplantation [P00] K. Slezáková *, M. Kušíková, M. Mistrík, E. Bojtárová Clinic of Hematology and Blood Transfusion, University Hospital, Antolská Bratislava 8507, Slovakia 060. The role of cell concentration at overnight storage and at cryopreservation on the viability and clonogenity of progenitor cells in peripheral blood stem cell harvests [P0] M. Hrubiško *, M. Siváková, O. Jánošová, M. Mistrík Department of Hematology and Transfusion Medicine, University Hospital, Bratislava, Slovakia 06. An influence of cytokine polymorphism on the outcome of allografted patients [P0] L. Raida *, E. Faber, K. Indrák, F. Mrázek, Z. Ambrůzová, M. Petřek, V. Koza 3, K. Langová 4 Hemato-oncology, University Hospital, Olomouc, Czech Republic, Immunology Dpt., University Hospital, Olomouc, Czech Republic, 3 Hemato-oncology Dpt., University Hospital, Plze`o, Czech Republic, 4 Dpt. of Biophysics, Medical School of Palacký University, Olomouc, Czech Republic 06. PCR-STR method in monitoring chimerism status after hematopoietic stem cell transplantation [P03] Z. Grubic *, K. Stingl, E. Cecuk-Jelicic, R. Zunec, R. Serventi-Seiwerth, Lj. Rajic 3, B. Labar, V. Brkljacic Kerhin Tissue Typing Centre, Croatia, Department of Hematology, Internal Clinic, Croatia, 3 Pediatric Clinic, University Hospital Centre Zagreb, Croatia 063. High-dose therapy and autologous transplantation in poor prognosis patients with diffuse large B-cell lymphoma in first remission [P0] T. Papajik *, L. Raida, E. Faber, V. Prochazka, J. Vondrakova, I. Skoumalova, Z. Kubova, M. Jarosova, J. Jarkovský, L. Dusek, K. Indrak Hemato-oncology Department, University Hospital Olomouc, Centre of Biostatistic and Analyses, Masaryk University Brno, Czech Republic Thursday 5

14 Friday 3 August 007 Number after the title in brackets is to identify the abstract in the Blood Reviews Educational Session Stem Cell Transplantation Pátria Room Chairpersons: Jerzy Holowiecki (Poland), Boris Labar (Croatia) 00. Hematopoietic stem cell transplantation in Europe-Economical and political implications [I05] Alois Gratwohl (Switzerland) 00. Endothelium and haematopoietic stem cell transplantation [I03] Enric Carreras (Spain) 003. Regenerative medicine: mesenchymal stem cell transplantation Francesco Frassoni (Italy) 004. Stem cell transplantation in multiple myeloma [I04] Gösta Gahrton (Sweden) Coffee Break Exhibition Area ISH-EAD Science and Education Committee Meeting Brahms Room Educational Session Transfusion Medicine Pátria Room Chairpersons: Lawrence D. Petz (USA), Izabella Hoffer (Hungary) 00. Bystander immune cytolysis [I07] Lawrence D. Petz (USA) 00. Development of transfusion medicine in Europe A challenge for physicians, scientists and politicians [I08] Erhard Seifried (Germany) 003. Unusual RhD phenotypes recent advances and clinical implications [I06] Günther Körmöczi (Austria) ISH-EAD Divisional Meeting Brahms Room Poster Viewing List of the posters can be found on page 3 Gallery Level Lunch Break Gallery Level Friday 7

15 Educational Session Anaemia Pátria Room Chairpersons: Karel Indrak (Czech Republic), Aaron Polliack (Israel) 00. Refractory iron deficiency anemia [I0] 003. Severe aplastic anaemia Chaim Hershko (Izrael) Edward Gordon-Smith (UK) 00. Thalassemia syndromes [I09] 004. Myelodysplastic syndromes (MDS) Maria Cappellini (Italy) Ghulam Mufti (UK) Satellite Symposium TEVA SYMPOSIUM Bartók Room Stable Blood Product Service in Hungary (in Hungarian language) Stabil vérkészítmény ellátás hazai helyzete 330 Üdvözlés Dr. Illés Béla főosztályvezető Teva Gyógyszergyár zrt Stabil vérkészítmény felhasználás hazai és nemzetközi adatai és trendek. Dr. Melicher Ferenc főosztályvezető helyettes Teva Gyógyszergyár zrt Az első gyógyszer alapanyag céljára friss fagyasztott plazmát aferezissel előállító plazmaferezis állomás létesítésének és működésének tapasztalatai. Dr. Illés Béla ügyvezető igazgató Plazmaferezis Állomás Kht A stabil vérkészítmények gyártásának és forgalombahozatalának engedélyezéséhez kapcsolódó PMF tartalmi követelményei. Dr. Boldoczki Mária osztályvezető Teva Gyógyszergyár zrt A stabil vérkészítmények forgalombahozatala előtti felszabadításának követelményei. Dr. Illésné Dr. Gallasz Judit csoportvezető Teva Gyógyszergyár zrt Hozzászólás, vita Coffee Break Exhibition Area Meet the Expert Pátria Room Challenging established opinions in the management of infectious complications in patients with hematologic diseases Panel: Ben de Pauw Professor of Medicine with special reference to the Supportive Care of Cancer Patients at the University Medical Centre, St Radboud at Nijmegen in The Netherlands. János Sinkó Attending Physician and Infectious Disease Consultant at two major centers for oncohematology and stem cell transplantation at St. László Hospital, as well as National Medical Center, Budapest, Hungary. Selected questions from the field of anti-infective treatment and prophylaxis in patients with hematologic diseases will be exposed. Attendees are welcome to share their views on current clinical practice and information supporting their choice. Data from relevant literature will subsequently be added by moderators to challenge established opinions and to initiate a fruitful discussion. 8 Friday

16 Oral Presentations Blood Transfusion Bartók Room Chairpersons: Nariman M. Zahran (Egypt), Judit Jakab (Hungary) Break 00. RhD positive or negative? Partial D antigen determination using gel card technique by DIAGAST D Screen system [O4] Z. Csernus *, K. Siba, V. Pászthy, I. Nemes NBTS Regional Blood Transfusion Center Pécs, Hungary 00. HCV infection and risk factors among Hungarian blood donors in colleges and universities [O5] É. Barabás *, Z. Péterfi Hungarian Blood Transfusion Service Budapest, Hungary 003. Irregular antibodies in the neonates [O6] S. Benkő *, J. Jakab, I. Zsigmond-Soós, Zs. Kristófi, N. Bedekovics Hungarian National Blood Transfusion Service, Regional Blood Transfusion Center, Immunhematology Dep., Budapest, Hungary 004. Frequency of red blood cell antibodies in adult patients [O7] E. Gazdag *, J. Jakab, I. Zsigmond-Soós, N. Golács, S. Benkő, M. Vagner, Zs. Kristófi, N. Bedekovich Hungarian National Blood Transfusion Service, Regional Blood Transfusion Center, Immunohematology Dep., Budapest, Hungary 005. Evaluation of the influence of storage time and prestorage leucodepletion on the accumulation of platelet derived biologic response modifiers in platelet concentrates [O8] N.M. Zahran * Department of Haematology, Theodor Bilharz Research Institute, Giza, Egypt Oral Presentations Lymphoma I. Pátria Room Chairpersons: Gábor Mikala (Hungary), Gyula Varga (Hungary) 00. Change in prognosis due to differences in cellular origin of diffuse large B-cell lymphoma in response to R-CHOP therapy [P38] T. Schneider *, E. Tóth, A. Matolcsy, Zs. Molnár, B. Deák, E. Várady, M. Lakos, A. Rosta National Institute of Oncology, Department of Hematology, Budapest, Hungary 00. Intensified CHOP as first line treatment in poor risk diffuse large B-cell non-hodgkin s lymphoma (DLBCL) patients [O0] A. Abdel Warith *, Th. Abdel Hamid, N. Mokhtar, H. Dawood National Cancer Institute, Egypt 003. A retrospective single-center experience with bortezomib-based therapy of relapsed and/or refractory multiple myeloma: survival results of our first 04 consecutive patients [O] G. Mikala *, A. Batai, I. Bodo, Z. Csukly, J. Dolgos, G. Halm, J. Janosi, B. Kapas, N. Lovas, S. Lueff, M. Peto, P. Remenyi, A. Sipos, Z. Toth, T. Masszi National Medical Center, Dept. Haematol. Stem Cell Transpl., Budapest, Hungary 004. Genetic lesions in multiple myeloma: prognostic and predictive significance in the era of the new drugs [O] R. Hajek *, P. Kuglik, R. Zaoralova, H. Greslikova, P. Nemec, J. Smejkalova Dep. of Internal Medicine and Hemato-Oncology, Faculty Hospital and Faculty of Medicine Brno, Czech Republic, Myeloma Basic Research Centre, Masaryk University, Brno, Czech Republic Friday 9

17 005. Proliferation and apoptosis in multiple myeloma prognostic factors or kinetic parameters? [O3] J. Minarik *, V. Scudla, M. Ordeltova, J. Bacovsky, M. Zemanova, T. Pika Department of Internal Medicine III, FH Olomouc, Olomouc, Czech Republic, Department of Clinical Immunology, FH Olomouc, Czech Republic 006. Immunological role of pathological phenotype in peripheral T-cell lymphoma [O4] L. Krenács *, E. Bagdi Laboratory of Tumor Pathology and Molecular Diagnostics, Institute of Biotechnology, Bay Zoltán Foundation for Applied Research, Szeged, Hungary Oral Presentations Stem Cell Transplantation Bartók Room Chairpersons: Péter Reményi (Hungary), Marianna Dávid (Hungary) OrgAn concert 00. The outcome of hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis in Korea [O5] T. Hwang *, J. Seo, H. Youn, J. Song, H. Im, H. Moon, M. Lee, T. Ghim, H. Shin, H. Ahn, K. Seong, H. Koo, D. Jeong, B. Cho, H. Kim, H. Kook Chonnam National University Hospital and Histiocytosis Working Party, the Korean Society of Hematology, Korea 00. A pilot study with autologous bone marrow-derived stem cell transplantation (ABSCT) in patients with severe peripheral arterial disorder (SPAD) [O6] Z. Boda *, K. Farkas 6,J. Tóth,L.Jámbor, P. Soltész, K. Rázsó, T. Sipos 3, M. Szarvas, Zs. Oláh, P. Ilonczai, K. Litauszky 4, Z. Veréb 5, E. Rajnavölgyi 5 University of Debrecen, nd and 3rd Department of Medicine, Department of Radiology, 3 Cell Therapy Center, 4 st Department of Surgery, 5 Department of Immunology, 6 Debrecen, St. Imre County Hospital, Budapest, Hungary 003. Present state of stem cell transplantation in Slovakia [O7] M. Mistrík *, J. Horáková, J. Hudeček 3, J. Lakota 4, I. Markuljak 5, S. Palašthy 6, E. Tóthová 7 Dpt. of Hematol. & Transfusiol., Faculty Hospital Bratislava; Pediatric Univ. Teaching Hosp., BMT Unit nd Children Clinic, Bratislava; Dpt. of Hematol. & Transfusiol., Univ. Hospital Martin; National Cancer Institute, Bratislava; Dpt. of Hematology, Roosevelt Hospital Banská Bystrica; Dpt. of Hematology, Faculty Hospital Prešov; Dpt. of Hematol. & Oncohematol., Univ. Hospital LF UPJS, Košice, Slovakia 004. Outcome of sibling reduced-intensity conditioning allogeneic stem cell transplantations in low-grade B-cell lymphoproliferative disorders [O8] M. Dávid *, R. Desmond, E. Conneally, P. Browne, S. McCann, M. Ni Chonghaile, E. Vandenberghe Department of Haematology, St. James s Hospital, Dublin, Ireland 005. A novel treosulfan-fludarabine (TreFlu) conditioning before allogeneic hematopoietic cell transplantation searching for reduced toxicity while preserving the treatment efficacy [O9] J. Holowiecki *, S. Giebel, J. Wojnar, M. Krawczyk-Kulis, I. Wylezol, K. Wozniczka, T. Czerw, M. Markiewicz, A. Holowiecka-Goral, K. Jankowska Dept. of Haematology and BMT, Silesian Medical University, Katowice, Poland 006. Effective mobilization of stem cells in multiple myeloma following priming by high-dose cyclophosphamide and bortezomib [P0] M. Reti, G. Mikala *, V. Goda, J. Janosi, M. Peto, T. Masszi National Medical Center, Dept. Haematol. Stem Cell Transpl., Budapest, Hungary 000 Shuttle buses will depart from the Congress Venue to the St. Stephan s Basilica af ter the Scientific Programme (at 95). Shuttle buses will depart from the St. Stephan s Basilica to the Hotels after the Organ Concert (at 00). 30 Friday

18 Posters Acute Leukaemia 00. Myeloperoxidase index and acute myeloid leukemia [P06] J. Eivazi-Ziaei * Tabriz University Hematology Oncology Research Centre (TUHORC), Tabriz University of Medical Sciences, Tabriz, Iran 00. Results of LINKER regimen in the treatment of adult acute lymphoblastic leukemia [P063] M. Benlazar *, A. Hadjeb, N. Si Ali, A. Maghraoiu, El Mestari, N. Zemri, I. Allal, Z. Zouaoui Haematology unit, Hospital of Sidi Bel Abbes, Algeria 003. Pegfilgrastim shortens aplasia in acute myeloid leukemia induction and consolidation therapy [P064] J. Várkonyi * 3rd Department of Internal Medicine. Semmelweis University, Budapest, Hungary 004. Cytogenetic and FISH findings are complementary in childhood ALL [P065] I. Haltrich *, G. Kovács, M. Csóka, Z. Jakab, G. Fekete Semmelweis University, II Department of Pediatrics, Budapest; Hungary 005. Biphenotypic and bilineal acute leukemia: report of 4 cases [P066] M. Bogunovic *, A. Bogdanovic, N. Kraguljac, V. Djordjevic, V. Lazarevic, G. Colovic, M. Jankovic, M. Gotic Institute of Hematology, Belgrade, Serbia 006. Monitoring of cardiotoxicity in hematooncology with cardiac biomarkers, echocardiography and electrocardiography [P067] J.M. Horacek, *, R. Pudil 3, M. Tichy,4, L. Jebavy,, P. Zak, L. Slovacek, Faculty of Military Health Sciences, Department of Internal Medicine, Hradec Kralove, Czech Republic, Charles University Hospital, Department of Medicine II Clinical Hematology, 3 Department of Medicine I, 4 Institute of Clinical Biochemistry and Diagnostics, Hradec Kralove, Czech Republic 007. Acute natural killer cell leukemia a challenge of diagnosis. Case report [P068] A.-M. Vlădăreanu *, H. Bumbea, M. Begu, D. Cîşleanu, C. Ciufu, V. Vasilache, A. Petre, M. Onisâi Emergency Universitary Hospital, Department of Hematology, Bucharest, Romania 008. Minimal residual disease in acute childhood leukemia [P069] J. Buslig *, M. Balogh, E. Bardi, C. Kiss, E. Olah, B. Scholtz UDMHSC. Dept. of Biochemistry and Molecular Biology, Dept. of Pediatrics, Debrecen, Hungary 009. Therapeutic use of recombinant erythropoietin in children with leukemias [P070] G.T. Kovacs *, J. Müller, M. Csóka, E. Vonnak, A. Farkas, Gy. Fekete nd Dep. of Pediatrics, Semmelweis University, Budapest, Hungary 00. Exploring WILMS tumour gene in acuteleukemias initial experiences [P07] L. Rejtő *, S. Bíró, B. Telek, A. Kiss, P. Batár,Gy. Reményi, R. Szász, N. Méhes, M. Udvardy Debrecen University Medical and Health Science Center, nd Internal, Department of Haematology, Debrecen, Hungary, DU MHSC Human Genetics Institute, Debrecen, Hungary 0. Mediastinal germ cell tumor and acute myeloid leukemia [P07] J. Csomor *, J. Sinkó, Z. Sápi, E. Ráthonyi, B. Timár, S. Fekete st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest; National Institute of Oncology, Budapest; Department of Hematology, Szt. László Hospital, Budapest 0. Bullous pyoderma gangrenosum and papular skin eruption as two simultaneous specific cutaneous manifestations of acute myelomonocytic leukemia [P073] I. Takács *, Zs. Károlyi, G. Radványi,N.Erős 4, F. Bozsó, I. Mórocz 3, A. Matolcsy 5 Department of Haematology, Dermatology and 3 Pathology, Semmelweis Teaching Hospital, Miskolc, Hungary, 4 Department of Dermatology, Venerology and Dermatooncology, 5 st Department of Pathology and Experimental Cancer Research, Semmelweis University, Faculty of Medicine, Budapest, Hungary 03. Jumping translocation of q in a case of childhood acute lymphoblastic leukemia, type L3 with t(8;4) [P074] B. Bessenyei *, A. Ujfalusi, E. Balogh, Cs. Kiss, E. Bárdi, I. Szegedi, É. Oláh Regional Genetic Laboratory, Dept. of Pediatrics, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary 04. Analysis of complex chromosome aberrations in childhood acute lymphoblastic leukemia (ALL) using multicolor fluorescent in situ hybridization (M-FISH) [P075] A. Ujfalusi *, E. Balogh, B. Bessenyei, Cs. Kiss, E. Bárdi, I. Szegedi, E. Oláh Regional Genetic Laboratory, Dept. of Pediatrics, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary 05. Identification of FLT3-ITD mutations in AML patients using different diagnostic methods [P076] P. Antal-Szalmás *, K. Koczok, I. Balogh, A. Kiss, M. Udvardy, J. Kappelmayer Department of Clinical Biochemistry and Molecular Pathology, nd Department of Internal Medicine, Debrecen, University of Debrecen, Medical and Health Science Center, Hungary 06. NPM and FLT3 mutations in acute myeloid leukemia [P077] S. Nahajevszky *, A. Tordai, A. Szilvasi, N. Meggyesi, E. Adam, A. Kozma, S. Lueff, N. Lovas, B. Kapas, Z. Matrai, A. Sipos, T. Masszi, H. Andrikovics Dept. of Hematology and Stem Cell Transplantation, Dept. of Molecular Diagnostics, National Medical Center, Budapest, Hungary 07. A rare FAB M7 specific chromosomal translocation and cytogenetic evidence for clonal evolution in adult AML [P078] A. Szőke *, E. Ádám, Sz. Modok, K. Piukovics, Gy. Varga, Z. Borbényi nd Dept. of Medicine and Cardiology Centre, University of Szeged, Hungary, National Medical Centre, Budapest, Hungary 08. Relation between magnetic fields and acute leukemia in children with Down syndrome [P079] J.M. Mejía-Aranguré *, A. Fajardo-Gutiérrez, M.L. Pérez-Saldivar, L. Velásquez-Pérez, R. Bernáldez-Ríos, R. Paredes-Aguilera, A. Martínez-Avalos, L. Romero-Guzmán, M. Ángeles del-campo-martínez, J. Flores-Lujano, F. Salamanca-Gómez, C. Gorodezky Instituto Mexicano del Seguro Social, Unit of Clinical Epidemiology, Mexico City, Mexico 3 Friday

19 09. Incidence of FLT-3 mutations in Iranian patients with acute myeloid leukaemia [P080] F. Zaker *, M. Mohammadi, A. Kazemi Iran University of Medical Sciences, Hemmat freeway, Dept of Hematology, Tehran, Iran Anaemia 00. Tracing the case of essential thrombocytosis caused by nourishing deficiency [P08] C. M. J. Malem * Laboratory Claudio Malem & associates General Alvear, Province of Mendoza, Argentinia 0. Usefulness of red blood cell flags in diagnosing and differentiating thalassemia trait from iron-deficiency anemia [P08] J. Eivazi-Ziaei *, S. Dastgiri, S. Ebrahimpour, R. Soltanpour, A. Mahmoudpour 3 Tabriz University Hematology and Oncology Research Center, Shahid Ghazi Ward, Imam Hospital, Danesh Clinical Laboratory, 3 Center for Biotechnology Research, Tabriz University of Medical Sciences, Tabriz, Iran 0. Effect of medical day unit in preventing hospital admissions in adult sickle disease patients presenting with painful crisis [P083] R. Amos, A. Mohammadi *, R. K. Govindarajan, I. Clarke Homerton University Hospital, Department of Hematology, London, UK 03. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children s Hospital experience [P085] N. Abdelrazik *. Mansoura University Children s Hospital, Department of pediatrics, Mansoura Faculty of Medicine, Mansoura, Egypt 04. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: A randomized case-controlled study [P086] N. Abdelrazik *, M. Fouda Department of Pediatrics, Pediatric Hematology, Oncology, and BMT unit, Mansoura University Children Hospital (MUCH), Department of Clinical Pathology and Hematology, Mansoura Faculty of Medicine, Mansoura, Egypt 05. Retrospective review of blood transfusion requirements of adult patients on extracorporeal membrane oxygenation (ECMO) [P087] A. L. Ang *, S. L. Tien, C. H. Lim, M. Koh,3 Singapore General Hospital, Haematology, Singapore, National Heart Centre, Cardiothoracic Surgery, Singapore, 3 Centre for Transfusion Medicine, Singapore 06. Study of EC cells in patients with pernicious anemia [P088] L. Macukanovic-Golubovic *, M. Milenovic, G. Marjanovic, M. Vucic, E. Simonovic, M. Mladenovic, G. Rancic Clinic of Haematology, Clinic of Pathology, Institute of Histology and Embriology, School of Medicine Nis, Nis, Serbia 07. Ferritine, transferrine and IST as a bone marrow iron depot predictor [P089] M. Barbón, E. de Cabo *, R. Carreño, A. M. Ojea, M. J. Moro Hospital de León, Hematology Service, Spain 08. Cyclosporine alternating with danazol treatment in autoimmune medular aplasia [P090] G. Gaman *, A. Gaman, C. Moisa Craiova Medical University, Hematology, Craiova, Romania 09. Intravenous ferric gluconate significantly improves response to epoetin alfa versus no iron in anemic patients with indolent lymphomas. A preliminary study [P09] P. Rajnics *, M. Egyed, B. Kollar, Gy. Rumi Kaposi Mór Teaching Hospital, Department of Internal Medicine, Division of Haematology, Hungary 030. Severe foetal and neonatal anaemia due to Kell alloimmunization [P09] S.Y. Soh *, S.H. Yeo, A.M. Tan Hematology/Oncology Service, Department of Paediatric Medicine Subspecialties, KK Women s and Children s Hospital, Singapore, Department of Maternal Foetal Medicine, KK Women s and Children s Hospital, Singapore 03. Treatment of iron-deficiency anemia with ferrous gluconate [P093] Č. D. Čeleketić*, V. Vukov, Z. Cvetković, D. Kostić Clinical Hospital Zemun-Belgrade, Department of Hematology and Immunology, Serbia 03. The effect of antioxidant treatment on red blood cells of porphyria cutanea tarda patients [P094] E. Székely *, A. Almási, Gy. Tasnádi,M.Bor, A. Vereckei, A. Lugasi 3, A. Blázovics 4 Central Hospital of the Hungarian State Railways Budapest, Hungarian Porphyria Center, 3rd Department of Internal Medicine, Semmelweis University, 3 National Institute for Food Safety and Nutrition, 4 nd Department of Medicine, Semmelweis University, Budapest, Hungary Blood Transfusion 033. A case of anti-xg a antibody [P095] M. Vagner *, É. Végh, I. Zsigmond-Soós, J. Jakab. Hungarian National Blood Transfusion Service, Regional Blood Transfusion Center, Department of Immunohematology, Budapest, Hungary, Szent László Hospital, Department of Oncology, Budapest, Hungary 034. HIV p4 reactivity in Hungarian blood donors without evidence of HIV infection [P096] E. Barabás *, M. Brózik Hungarian Blood Transfusion Service Budapest, Hungary, Natl. Inst. for Rheumatology and Physiotherapy, Budapest, Hungary 035. Occurence of irregular antibodies on basis of the data of the past five years (00 006) [P097] K. Szabó *, K. Molnár, K. Vörös Regional Blood Center Győr, Hungary 036. Neonatal alloimmune thrombocytopenia serological investigations in 006 [P098] J. Hriczkó *, J. Jakab, I. Zsigmond-Soós, S. Benkő, L. Kalász, I. Petri Hungarian National Blood Transfusion Service, Regional Blood Transfusion Center, Immunohematology Dep., Budapest, Hungary Friday 33

20 037. Haemotherapy and its serological aspects of patients suffering from immunohaematological diseases [P099] I. Bodorkós *, M. Aleksza, E. Horváth, T. Dancza, A. Farkas, A. Györkös, M. Kovács, M. Tiboly, P. Tóth, B. Gasztonyi OVSZ Zalaegerszegi Területi Vérellátó, Hungary, Zala Megyei Kórház Belgyógyászat Haematologia-Immunologia, Hungary 038. RBC alloimmunization in chronic transfusion patients (thalassemics) [P00] A. Azarkeivan *, M.H. Ahmadi, A. Gharebaghian, S. Nasizadeh, S. Zolfaghari, M. Maghsoodlu, M.B. Ayoub 039. Coincidental occurrence of RBC and HLA class I antibodies in renal transplant patients [P0] L. Kozma *, M. Lukovics, I. Bohaty Regional Blood Transfusion Center of Debrecen, Hungary 040. Seroprevalence of Hepatitis C among voluntary blood donors in South-Eastern Hungary [P0] E. Szekeres *, A. Frank, M. Kosa, G. Samu, V. Szekeres Szeged Regional Blood Center, Hungarian National Blood Transfusion Service, Szeged, Hungary 04. Development of compatibility testing techniques in Hungary [P03] A. Friss * National Blood Transfusion Service, Reference Laboratory, Budapest, Hungary 04. Red cell antibody screening with DiaMed card and with ACT 4 semi-automatic agglutination analyser based on the detection of red cell antibodies [P04] K. Szabo *, I. Zsigmond-Soós, J. Jakab, N. Golács, Zs. Kristófi, R. Tamás, M. Vagner, I. Hoffer Blood Bank of Hospital Vaszary Kolos in Esztergom, Hungary, Immunohematology Department of the National Blood Transfusion Service (OVSZ) Regional Blood Transfusion Centre in Buda (BRVK) Budapest, Hungary 043. Evaluation of automated immunohematologic system in routine blood group serology testing [P05] A. Fehér *, I. Zs. Soós, G. Bekő Semmelweis University Central Laboratory, Budapest, Hungary, OVSZ-Buda-side Regional Blood Diagnostic Department, Budapest, Hungary 044. Quality measurements from blood donation to separation [P06] M. Aleksza *, I. Bodorkós, É. Horváth, I. Katovics, K. Baróti, T. Dancza National Blood Centre of Hungary, Regional Blood Bank of Zalaegerszeg, Quality Control Laboratory, Hungary Chronic Myeloproliferative Diseases 045. Chromosomal abnormalities in Philadelphia chromosomenegative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase [P07] S. Jootar * Ramathibodi Hospital, Rama 6 Road, Bangkok 0400, Thailand 046. Central nervous system blastic phase in chronic myeloid leukaemia during imatinib treatment [P08] A. Kiss *, A. Ujfalusy, T. Csepany 3, Gy. Remenyi, P. Batar, E. Balogh, M. Udvardy nd Department of Medicine, Pediatry, 3 Neurology Clinic, University Debrecen, Hungary 047. Systemic mastocytosis with partial response to cladribine [P09] N. Čolović *, M. Sretenović, T. Terzić, M. Čolović, V. Jurišić Institute of Hematology, Clinical Center of Serbia, Koste Todorovića, Belgrade, Serbia 048. Defect of JAK/STAT5 signalling pathway in essential thrombocythemia and myelofibrosis. (Hypothesis: Malignant Stem Cell transformation) [P0] E. Gulya *, P. Gombás,A. Kárpáti, K. Kristó, A. Matolcsy, Z. Mátrai 3, K. Pecze 4 Central Hospital of MI, Oncology, Sememelweis Univ., Dept. of Pathology and Experimental Cancer Research, 3 National medical Center, Dept. of Hematol. and Stem Cell Transplantation, 4 Árpád Kórház Budapest, Hungary 049. Glivec treatment in the nd Department of Medicine, University of Debrecen, Hungary ( ) [P] A. Kiss *, B. Telek, L. Rejtő, G. Reményi, P. Batár, E. Balogh, A. Ujfalusy, P. Szalmás Antal 3, V. Józsa, M. Udvardy nd Department of Medicine, Pediatry, 3 Central Laboratory, University of Debrecen, Hungary 050. Defects in platelet surface antigens in chronic myeloproliferative syndrome identified by flow cytometry analysis [P] H. Bumbea *, A.-M. Vladareanu, S. Radesi, V. Vasilache, C. Ciufu, A. Petre, D. Cisleanu, M. Begu, I. Voican, C. Marinescu, V. Popov, M. Onisai, M. Dervesteanu Emergency Universitary Hospital, Department of Hematology, Bucharest, Romania, County Hospital, Pitesti, Romania 05. Analysis of polycythemia vera and essential thrombocythemia by lineage specific investigation of JAKV67F mutation and X-linked clonality assay [P3] P. Jáksó *, Z. Nagy, L. Kereskai, D. Alpár, B. Kajtár, L. Pajor University of Pécs, Department of Pathology, Pécs, Hungary 05. JAK mutation in polycythaemia vera and essential thrombocythaemia [P4] P. Batar *, E. Kelemen, B. Telek, Gy. Remenyi, A. Kiss, L. Rejto, M. Udvardy University of Deberecen, Health Sciences Center, nd Dept. of Medicine, Debrecen, Hungary 053. Nilotinib (AMN 07) plus involved field irradiation therapy in extramedullary lymphoid and medullary myeloid blast crisis of chronic myeloid leukemia [P5] Z. Csukly *, A. Bátai, B. Kapás, S. Lueff, P. Reményi, A. Sipos, J. Csomor, E. Ádám, H. Andrikovics, T. Masszi National Medical Center, Hematology and Stem Cell Transplantation, Budapest, Hungary 054. Simultaneous appearance of +8 in Ph+ and Ph- cells during imatinib treatment of CML: a report of two cases [P6] B. Kajtár *, J. Tóth, D. Alpár, P. Jáksó, L. Kereskai, R. László, Z. Nagy, L. Pajor University of Pécs, Department of Pathology, Pécs, Hungary 34 Friday

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology

Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also

More information

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers

More information

Careers in Haematology

Careers in Haematology Careers in Haematology A Guide for Medical Students and Junior Doctors Haematology is the medical speciality concerned with blood disorders. Your non-medical friends however will always think that you

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll

More information

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April 2013. Reference: NHSCB/B04/P/a

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April 2013. Reference: NHSCB/B04/P/a Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation First published:

More information

MEDICAL COVERAGE POLICY

MEDICAL COVERAGE POLICY Important note Even though this policy may indicate that a particular service or supply is considered covered, this conclusion is not necessarily based upon the terms of your particular benefit plan. Each

More information

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine

Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells

More information

Stem Cell Transplantation

Stem Cell Transplantation Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

What we will discuss today

What we will discuss today Umbilical cord blood banking It s Utility? Dr. Nita Radhakrishnan Pediatric Hematology Oncology Unit, Sir Ganga Ram Hospital, New Delhi What we will discuss today What are stem cells? What are the sources

More information

information for payers and referrers

information for payers and referrers a d u lt s t e m c e l l t r a n s p l a n tat i o n p r o g r a m information for payers and referrers Spring 2014 For more information, visit www.dfbwcc.org/bmt. o u r expertise Since its founding in

More information

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each

Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including

More information

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014 ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the

More information

P R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation

P R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation TABLE OF CONTENTS About the European Group for Blood and Marrow Transplantation Haematopoietic Stem Cell Transplantation (HSCT): Key facts & figures EBMT Data - A foundation for cutting-edge research Clinical

More information

Disclosures. I have no disclosures.

Disclosures. I have no disclosures. Not Your Own Marrow Jenni Krajewski, MD Clinical Assistant Professor, Rutgers New Jersey Medical School Attending Physician, Pediatric Blood and Marrow Transplantation The Institute for Pediatric Cancer

More information

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center

Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center (last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical

More information

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa

Pros and Cons of Stem Cell Sources and their availability in Africa. Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Pros and Cons of Stem Cell Sources and their availability in Africa Dr Jaimendra Singh Inkosi Albert Luthuli Central Hospital Durban, South Africa Introduction The ability to perform a haematopoietic stem

More information

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer

More information

Reference: NHS England B04/P/a

Reference: NHS England B04/P/a Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation (HSCT) (All Ages): Revised Reference: NHS England B04/P/a 1 NHS England Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation

More information

Cord Blood Stem Cell Transplantation

Cord Blood Stem Cell Transplantation LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral

More information

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood

Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood [Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,

More information

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the

More information

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION

CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation

More information

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and

More information

Bone Marrow/Stem Cell Transplant

Bone Marrow/Stem Cell Transplant Blue Distinction Centers for Transplants Program Selection Criteria for 2010 Mid-Point Designations To qualify as a Blue Distinction Center for Transplants (), each facility must satisfy s quality based

More information

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank Cordblood Stem Cells and The Role of Cordblood Bank in Supporting Stem Cells Research Presentation Overview Company profile Haematopoietic stem cells in cordblood What we can do to help 1 2 PT CordLife

More information

Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation

Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation Dr Ros Ganderton, Ms Kate Parratt, Dr Debbie Richardson, Dr Kim Orchard and Dr Liz Hodges Departments of Molecular Pathology

More information

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation: Questions and Answers. Key Points CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Bone Marrow Transplantation

More information

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem_cell_transplantation_for_breast_cancer

More information

Jamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center

Jamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center Jamie Peregrine, MD, PGY-4 KU-Wichita, OB/GYN Wesley Medical Center Uses for umbilical cord stem cells Describe the indications and uses for umbilical cord stem cells. Counsel patients on the advantages

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

Donation of Umbilical Cord Blood. A precious life offer. for everyone!

Donation of Umbilical Cord Blood. A precious life offer. for everyone! Donation of Umbilical Cord Blood A precious life offer for everyone! Donation of Umbilical Cord Blood A precious life offer for everyone! Page 3 Hellenic Cord Blood Bank Page 4 Haematopoietic Progenitor

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_epithelial_ovarian_cancer 2/2001 11/2015 11/2016 11/2015 Description

More information

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?

Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype? Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in

More information

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide

Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood

More information

BLOOD AND MARROW TRANSPLANT PROGRAM

BLOOD AND MARROW TRANSPLANT PROGRAM BLOOD AND MARROW TRANSPLANT PROGRAM We offer a team approach to patient care that centers around our patients and their caregivers; we focus on providing comprehensive, holistic care for the best possible

More information

FastTest. You ve read the book... ... now test yourself

FastTest. You ve read the book... ... now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. Please refer back to relevant sections

More information

Blood-Forming Stem Cell Transplants

Blood-Forming Stem Cell Transplants Blood-Forming Stem Cell Transplants What are bone marrow and hematopoietic stem cells? Bone marrow is the soft, sponge-like material found inside bones. It contains immature cells known as hematopoietic

More information

SAVE A LIFE... BY GIVING LIFE!

SAVE A LIFE... BY GIVING LIFE! SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the

More information

UMBILICAL CORD BLOOD, STEM CELL BANKING

UMBILICAL CORD BLOOD, STEM CELL BANKING UMBILICAL CORD BLOOD, STEM CELL BANKING Dr.Sharad Jain MD Blood Transfusion officer, & I/C Transfusion Medicine NSCB Medical College. Jabalpur.MP. Introduction: Every parent during childbirth DREAMS the

More information

Interesting Case Series. Periorbital Richter Syndrome

Interesting Case Series. Periorbital Richter Syndrome Interesting Case Series Periorbital Richter Syndrome MarkGorman,MRCS,MSc, a Julia Ruston, MRCS, b and Sarath Vennam, BMBS a a Division of Plastic Surgery, Royal Devon and Exeter Hospital, Exeter, Devon,

More information

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE

UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE UMBILICAL CORD BLOOD TRANSPLANTATION: KFSH EXPERIENCE HIND AL HUMAIDAN, MD,FRCPA Director, Blood Bank (Donor & Transfusion Services) and Stem Cell Cord Blood Bank Consultant Hematopathologist INTRODUCTION

More information

Leukemias and Lymphomas: A primer

Leukemias and Lymphomas: A primer Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

Malignant Lymphomas and Plasma Cell Myeloma

Malignant Lymphomas and Plasma Cell Myeloma Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations

More information

Stem Cell Banking. Umbilical Cord. The Leading Cell Bank www.stemology.co.uk. Protect your family s future

Stem Cell Banking. Umbilical Cord. The Leading Cell Bank www.stemology.co.uk. Protect your family s future Protect your family s future The Leading Cell Bank www.stemology.co.uk Stem Cell Banking Umbilical Cord For women in their 1st, 2nd or 3rd Trimester of Pregnancy Introduction to Stemology Imagine you

More information

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012-2020

More information

Elenco dei periodici elettronici in Ovid Full text

Elenco dei periodici elettronici in Ovid Full text Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders

More information

Acute myeloid leukaemia (AML) in children

Acute myeloid leukaemia (AML) in children 1 61.02 Acute myeloid leukaemia (AML) in children AML can affect children of any age, and girls and boys are equally affected. Leukaemia Acute myeloid leukaemia (AML) FAB classification of AML Causes of

More information

Cancer services children s CSCF v3.2

Cancer services children s CSCF v3.2 Cancer services children s CSCF v3.2 Module overview Please note: This module should be read in conjunction with the Fundamentals of the Framework (including glossary and acronym list), Children s Services

More information

National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be

National Cancer Institute Research on Childhood Cancers. In the United States in 2005, approximately 9,510 children under age 15 will be CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s National Cancer Institute

More information

Not All Stem Cells are the Same

Not All Stem Cells are the Same Cord Blood Banking and Transplantation Jennifer Willert, M.D. Hematology/Oncology Blood and Marrow Transplant Rady Children s Hospital San Diego Clinical Professor UCSD Not All Stem Cells are the Same

More information

UMBILICAL CORD BLOOD BANKING A guide for parents

UMBILICAL CORD BLOOD BANKING A guide for parents UMBILICAL CORD BLOOD BANKING A guide for parents 2 nd EDITION INTRODUCTION The cells contained in the umbilical cord blood have therapeutic value for the treatment of blood disorders and immune diseases.

More information

What is chronic lymphocytic leukaemia?

What is chronic lymphocytic leukaemia? Revised October 2011 What is chronic lymphocytic leukaemia? The diagnosis of a blood cancer can be a devastating event for patients, families and friends. It is therefore vital for everyone to have access

More information

Corporate Medical Policy Cord Blood as a Source of Stem Cells

Corporate Medical Policy Cord Blood as a Source of Stem Cells Corporate Medical Policy Cord Blood as a Source of Stem Cells File Name: Origination: Last CAP Review: Next CAP Review: Last Review cord_blood_as_a_source_of_stem_cells 2/2001 3/2015 3/2016 3/2015 Description

More information

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris

Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Bone Marrow, Peripheral Blood Stem Cells or Umbilical Cord Blood transplantation? Federica Giannotti, MD Eurocord-Hôpital Saint Louis, Paris Background Hematopoietic stem cell transplantation (HSCT) is

More information

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant

The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant Speech by Dr. Tsuneo A. Takahashi Translated by Stella Wang Japan and the United States are the two most experienced countries

More information

A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology

A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology A Framework of Competences for the Level 3 Training Special Study Module in Paediatric Oncology Feb 2010 Royal College of Paediatrics and Child Health www.rcpch.ac.uk Royal College of Paediatrics and Child

More information

Treatment of low-grade non-hodgkin lymphoma

Treatment of low-grade non-hodgkin lymphoma Produced 28.02.2011 Due for revision 28.02.2013 Treatment of low-grade non-hodgkin lymphoma Lymphomas are described as low grade if the cells appear to be dividing slowly. There are several kinds of low-grade

More information

GRANIX (tbo-filgrastim)

GRANIX (tbo-filgrastim) RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil

More information

Outline of thesis and future perspectives.

Outline of thesis and future perspectives. Outline of thesis and future perspectives. This thesis is divided into two different sections. The B- section involves reviews and studies on B- cell non- Hodgkin lymphoma [NHL] and radioimmunotherapy

More information

Aggressive lymphomas. Michael Crump Princess Margaret Hospital

Aggressive lymphomas. Michael Crump Princess Margaret Hospital Aggressive lymphomas Michael Crump Princess Margaret Hospital What are the aggressive lymphomas? Diffuse large B cell Mediastinal large B cell Anaplastic large cell Burkitt lymphoma (transformed lymphoma:

More information

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.

5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements. WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries

More information

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002

INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 INFORMATION ON STEM CELLS/BONE MARROW AND REINFUSION/TRANSPLANTATION SUR703.002 COVERAGE: SPECIAL COMMENT ON POLICY REVIEW: Due to the complexity of the Peripheral and Bone Marrow Stem Cell Transplantation

More information

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2

Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2 Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2 Leukaemia: Description A group of malignant disorders affecting: White blood cells (lymphocytes or leucocytes) Bone

More information

Therapeutic Potential of Cells Derived from Gestational Tissues: A coming of age. Dr Roisin Deane Cell Care Australia Pty Ltd

Therapeutic Potential of Cells Derived from Gestational Tissues: A coming of age. Dr Roisin Deane Cell Care Australia Pty Ltd Therapeutic Potential of Cells Derived from Gestational Tissues: A coming of age Dr Roisin Deane Cell Care Australia Pty Ltd What are Gestational Stem Cells? Stem cells isolated from the gestational tissues

More information

Technical University of Mombasa Faculty of Applied and Health Sciences

Technical University of Mombasa Faculty of Applied and Health Sciences Technical University of Mombasa Faculty of Applied and Health Sciences DEPARTMENT OF MEDICAL SCIENCES UNIVERSITY EXAMINATION FOR THE DEGREE OF BACHELOR OF MEDICAL LABORATORY SCIENCES BMLS 12S Mid AML 4321

More information

A Career in Pediatric Hematology-Oncology? Think About It...

A Career in Pediatric Hematology-Oncology? Think About It... A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T

More information

umbilical cord blood banking A guide for parents

umbilical cord blood banking A guide for parents umbilical cord blood banking A guide for parents 2 nd Edition 2016 This guide has been elaborated by the Council of Europe European Committee on Organ Transplantation (CD-P-TO). For more information, please

More information

Cord blood Banking Transplant List for One USA Bank - StemCyte www.stemcyte.com/cordblood-banking-transplant-list

Cord blood Banking Transplant List for One USA Bank - StemCyte www.stemcyte.com/cordblood-banking-transplant-list Cells4Life is the oldest and largest cord blood storage company in the UK. We are governed by some of the world's most stringent medical laws, and are currently the only stem cell storage company in the

More information

Future Health Technologies. From Academia to Industry The Stem Cell Challenge. Roger J. Dainty MBE FIScT UK Managing Director

Future Health Technologies. From Academia to Industry The Stem Cell Challenge. Roger J. Dainty MBE FIScT UK Managing Director Future Health Technologies From Academia to Industry The Stem Cell Challenge Roger J. Dainty MBE FIScT UK Managing Director How Did I Get Here? Working as a Research Medical Technician (Birmingham University

More information

The Facts about Cord Blood

The Facts about Cord Blood The Facts about Cord Blood Dear Future Mom and/or Dad, All of us at CorCell would like to give you a big CONGRATULATIONS on your new baby! Now that you are expecting, you have probably heard about saving

More information

What is a Stem Cell Transplantation?

What is a Stem Cell Transplantation? What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am

More information

UMBILICAL CORD BLOOD HARVESTING & STORAGE

UMBILICAL CORD BLOOD HARVESTING & STORAGE Protocol: TRP009 Effective Date: October 14, 2013 UMBILICAL CORD BLOOD HARVESTING & STORAGE Table of Contents Page COMMERCIAL, MEDICARE & MEDICAID COVERAGE RATIONALE... 1 BACKGROUND... 2 CLINICAL EVIDENCE...

More information

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer

Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Breast Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem_cell_transplantation_for_breast_cancer

More information

PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA

PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA UNFAVORABLE Advanced age High leukocyte count at diagnosis Presence of myeloid antigens Late achievement of CR Chromosomal abnormalities: t(9:22)(q34:q11) t(4;11)(q21;q23)

More information

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Update in Hematology Oncology Targeted Therapies. Mark Holguin Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning

More information

Haematopoietic stem cell transplantation in Hong Kong

Haematopoietic stem cell transplantation in Hong Kong S C I E N T I F I C P A P E R Haematopoietic stem cell transplantation in Hong Kong Albert KW Lie WY Au Raymond Liang 李 國 維 區 永 仁 梁 憲 孫 The first case of haematopoietic stem cell transplant (HSCT) was

More information

OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE SUBSETS AND THEIR FUNCTIONS OVERVIEW OF NORMAL LYMPH

OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE SUBSETS AND THEIR FUNCTIONS OVERVIEW OF NORMAL LYMPH AN INTRODUCTION TO THE LYMPHOPROLIFERATIVE DISORDERS BY DR Y PERNER DEPARTMENT OF ANATOMICAL PATHOLOGY OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE

More information

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational

More information

XX. International Semmelweis Symposium. 04-05. November 2011. Organ transplantation in the XXI. century SOLID ORGAN TRANSPLANTATION-AN UPDATE

XX. International Semmelweis Symposium. 04-05. November 2011. Organ transplantation in the XXI. century SOLID ORGAN TRANSPLANTATION-AN UPDATE XX. International Semmelweis Symposium 04-05. November 2011 Organ transplantation in the XXI. century SOLID ORGAN TRANSPLANTATION-AN UPDATE Conference chairs: Tivadar Tulassay, Rector of Semmelweis University

More information

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease

Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease Bone Marrow (Stem Cell) Transplant for Sickle Cell Disease 1 Produced by St. Jude Children s Research Hospital Departments of Hematology, Patient

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham

An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham An overview of CLL care and treatment Dr Dean Smith Haematology Consultant City Hospital Nottingham What is CLL? CLL (Chronic Lymphocytic Leukaemia) is a type of cancer in which the bone marrow makes too

More information

In extenso papers, basis of the dissertation (found in Appendix)

In extenso papers, basis of the dissertation (found in Appendix) LIST OF PUBLICATIONS In extenso papers, basis of the dissertation (found in Appendix) 1. Molnár Zs. Positron emission Tomography (PET) in diagnosis and clinical management of malignant lymphomas. Haemat

More information

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7

10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program. Thursday, June 7 10 th Annual International Cord Blood Transplantation Symposium June 7-9, 2012 Preliminary Scientific Program Thursday, June 7 7:00 8:00 AM Breakfast in Exhibit Hall Session IA 8:00 10:00 AM Advances in

More information

CHAPTER 26 LATE BREAKING DEVELOPMENTS: IMPACT OF ANTI-CD20 MONOCLONAL ANTIBODIES ON LYMPHOMA THERAPY

CHAPTER 26 LATE BREAKING DEVELOPMENTS: IMPACT OF ANTI-CD20 MONOCLONAL ANTIBODIES ON LYMPHOMA THERAPY CHAPTER 26 LATE BREAKING DEVELOPMENTS: IMPACT OF ANTI-CD20 MONOCLONAL ANTIBODIES ON LYMPHOMA THERAPY 26.1 Introduction rituximab Subsequent to the completion of drafts for the guidelines earlier in 2004,

More information

NCIS/NUH stem cell transplant programme receives international accreditation

NCIS/NUH stem cell transplant programme receives international accreditation 30 October 2012 For immediate release MEDIA RELEASE NCIS/NUH stem cell transplant programme receives international accreditation First Asian programme to be recognised by the Foundation for the Accreditation

More information

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

Current Multiple Myeloma Treatment Adapted From the NCCN Guidelines

Current Multiple Myeloma Treatment Adapted From the NCCN Guidelines Current Multiple Myeloma Treatment Adapted From the NCCN Guidelines Diagnosis Survival 3-5 yrs Survival

More information

CML. cure. A Patient s Guide. Molecular Biology Diagnosis Stem Cell Transplant Monitoring New Drugs Questions to Ask and More

CML. cure. A Patient s Guide. Molecular Biology Diagnosis Stem Cell Transplant Monitoring New Drugs Questions to Ask and More A Patient s Guide to CML Molecular Biology Diagnosis Stem Cell Transplant Monitoring New Drugs Questions to Ask and More cure C a n c e r U p d at e s, R e s e a r c h & E d u c at i o n Based on science,

More information

Cord Blood: Research Progress and Future Promise

Cord Blood: Research Progress and Future Promise Cord Blood: Research Progress and Future Promise By Al Staropoli, AABB Contributing Writer Sue Fister found out she had leukemia when she was 50 years old. Doctors suggested a bone marrow transplant as

More information

FACULTY OF ALLIED HEALTH SCIENCES

FACULTY OF ALLIED HEALTH SCIENCES FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes

More information

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders

2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders UPDATE ECIL-4 2011 2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders Jan Styczynski, Hermann Einsele, Rafael de la Camara, Catherine Cordonnier,

More information

Blood and Marrow Stem Cell Transplantation

Blood and Marrow Stem Cell Transplantation Blood and Marrow Stem Cell Transplantation Revised 2013 A Message from Louis J. DeGennaro, PhD President and CEO of The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society (LLS) is committed to

More information

Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases

Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases Role of taxanes in the treatment of advanced NHL patients: A randomized study of 87 cases R. Shraddha, P.N. Pandit Radium Institute, Patna Medical College and Hospital, Patna, India Abstract NHL is a highly

More information

Fields of Education. Last updated August 2011

Fields of Education. Last updated August 2011 Fields of Education Last updated August 2011 Monash University is required to report to the Department of Education, Employment and Workplace Relations (DEEWR) the number of higher degree by research (HDR)

More information

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA Interesting Case Review Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA History 63 y/o male with h/o CLL for 10 years Presents with worsening renal function and hypercalcemia

More information

»medical programs and services. transfusion medicine fellowship program

»medical programs and services. transfusion medicine fellowship program »medical programs and services transfusion medicine fellowship program new york blood center transfusion medicine fellowship program» Experience at one of the largest nonprofit, community-based blood centers

More information

Therapeutic Treatment Options: Chronic Blood Transfusions Bone Marrow Transplantation. Marianne E. McPherson Yee, MD, MSc

Therapeutic Treatment Options: Chronic Blood Transfusions Bone Marrow Transplantation. Marianne E. McPherson Yee, MD, MSc Therapeutic Treatment Options: Chronic Blood Transfusions Bone Marrow Transplantation Marianne E. McPherson Yee, MD, MSc Sickle Cell Treatment Options Supportive Care Newborn Screen PCN Immunizations Education

More information

Umbilical Cord Blood Stem Cells Current Status & Future Potential

Umbilical Cord Blood Stem Cells Current Status & Future Potential Umbilical Cord Blood Stem Cells Current Status & Future Potential Natasha Ali Assistant Professor Haematology Department of Pathology & Laboratory Medicine/Oncology The Aga Khan University Email: natasha.ali@aku.edu

More information